p53 suppresses phosphoglycerate mutase (PGM), GLUT1, GLUT3, and GLUT4 expression (Kawauchi et al., 2008; Vousden and Ryan, 2009); hence, p53 mutation leads to an increased glycolysis in breast cancer. Here, SLC2A1 is linked to breast carcinoma.